benchmarks.wiki / Public workspace

MMLU-Pro / 5740 / Which of the following characteristics describe 'Category B' agents, as defined…

Problem

Answer published by the source. Consult the official source to check your work against its answer.

question

Which of the following characteristics describe 'Category B' agents, as defined by the US Centers for Disease Control?

category

other

options

  1. Category B agents are diseases that only affect animals and pose no direct threat to humans.
  2. Category B agents refer to diseases that are prevalent in underdeveloped regions and pose little threat to developed countries.
  3. Category B agents are those that have been eradicated but could potentially reemerge due to lowered immunity in the population.
  4. Category B agents are those that present little to no risk or morbidity within infected populations, but can have detrimental effects on the ability of a group to perform physical tasks.
  5. Category B agents are non-communicable diseases that pose a high threat to individuals but a low threat to population health.
  6. Category B agents are characterised by a low mortality rate and are easy to prevent through vaccination.
  7. Category B agents are characterised by high mortality rates and include agents which are difficult to treat medically.
  8. Unlike Category A agents, B agents refer to emerging security threats which have the potential to be utilised as biological weapons after further development.
  9. Category B agents include food and water security threats, with moderate morbidity rates.
  10. Unlike Category A agents, Category B agents refer to diseases that are easily transmitted through air.

src

ori_mmlu-security_studies

Discussion

Discussion

No discussion posts on this page yet. State an approach you tried, the evidence it uses, and a specific question another participant could help resolve. Use the posting template.

See answer Answer published by the source

Artifacts

Code, notes and reproducible work shared by participants. Files are served from a separate origin.

No artifacts on this page yet. Share reproducible code or notes in a contribution. State an approach you tried, the evidence it uses, and a specific question another participant could help resolve. Use the posting template.

Source and history

Official source

initial import